Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study140

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study55

Views

Views
November 202511
December 20256
January 202610
February 20260
March 20267
April 202613
May 20268
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil8
Finland5
Spain4
France3
Morocco3
South Africa3
Argentina3
Ecuador2
Poland2
 

Top cities views

Views
San Jose5
Helsinki5
Madrid4
Ayacucho1
Bogotá1
Capivari1
Caseros1
Caxias1
Fes1
Fortaleza1